Abstract

Review of reports of fatalities with allergenic extracts submitted to FDA is ongoing. Post marketing survey of serious adverse reactions associated with licensed grass pollen extracts is under development.

  Funding Agency

Agency
National Institute of Health (NIH)
Institute
Food and Drug Administration (FDA)
Type
Intramural Research (Z01)
Project #
1Z01BI001005-07
Application #
5200655
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
7
Fiscal Year
1995
Total Cost
Indirect Cost